IBDEI2TE ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,47257,1,4,0)
 ;;=4^C81.13
 ;;^UTILITY(U,$J,358.3,47257,2)
 ;;=^5001404
 ;;^UTILITY(U,$J,358.3,47258,0)
 ;;=C81.14^^209^2346^386
 ;;^UTILITY(U,$J,358.3,47258,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47258,1,3,0)
 ;;=3^Nodular Sclerosis Classical Hodgkin Lymphoma,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,47258,1,4,0)
 ;;=4^C81.14
 ;;^UTILITY(U,$J,358.3,47258,2)
 ;;=^5001405
 ;;^UTILITY(U,$J,358.3,47259,0)
 ;;=C81.15^^209^2346^387
 ;;^UTILITY(U,$J,358.3,47259,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47259,1,3,0)
 ;;=3^Nodular Sclerosis Classical Hodgkin Lymphoma,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,47259,1,4,0)
 ;;=4^C81.15
 ;;^UTILITY(U,$J,358.3,47259,2)
 ;;=^5001406
 ;;^UTILITY(U,$J,358.3,47260,0)
 ;;=C81.16^^209^2346^388
 ;;^UTILITY(U,$J,358.3,47260,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47260,1,3,0)
 ;;=3^Nodular Sclerosis Classical Hodgkin Lymphoma,Intrapelvic Nodes
 ;;^UTILITY(U,$J,358.3,47260,1,4,0)
 ;;=4^C81.16
 ;;^UTILITY(U,$J,358.3,47260,2)
 ;;=^5001407
 ;;^UTILITY(U,$J,358.3,47261,0)
 ;;=C81.17^^209^2346^389
 ;;^UTILITY(U,$J,358.3,47261,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47261,1,3,0)
 ;;=3^Nodular Sclerosis Classical Hodgkin Lymphoma,Spleen
 ;;^UTILITY(U,$J,358.3,47261,1,4,0)
 ;;=4^C81.17
 ;;^UTILITY(U,$J,358.3,47261,2)
 ;;=^5001408
 ;;^UTILITY(U,$J,358.3,47262,0)
 ;;=C81.18^^209^2346^390
 ;;^UTILITY(U,$J,358.3,47262,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47262,1,3,0)
 ;;=3^Nodular Sclerosis Classical Hodgkin Lymphoma,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,47262,1,4,0)
 ;;=4^C81.18
 ;;^UTILITY(U,$J,358.3,47262,2)
 ;;=^5001409
 ;;^UTILITY(U,$J,358.3,47263,0)
 ;;=C81.19^^209^2346^391
 ;;^UTILITY(U,$J,358.3,47263,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47263,1,3,0)
 ;;=3^Nodular Sclerosis Classical Hodgkin Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,47263,1,4,0)
 ;;=4^C81.19
 ;;^UTILITY(U,$J,358.3,47263,2)
 ;;=^5001410
 ;;^UTILITY(U,$J,358.3,47264,0)
 ;;=C81.20^^209^2346^331
 ;;^UTILITY(U,$J,358.3,47264,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47264,1,3,0)
 ;;=3^Mixed Cellularity Classical Hodgkin Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,47264,1,4,0)
 ;;=4^C81.20
 ;;^UTILITY(U,$J,358.3,47264,2)
 ;;=^5001411
 ;;^UTILITY(U,$J,358.3,47265,0)
 ;;=C81.21^^209^2346^332
 ;;^UTILITY(U,$J,358.3,47265,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47265,1,3,0)
 ;;=3^Mixed Cellularity Classical Hodgkin Lymphoma,Head/Face/Neck Nodes
 ;;^UTILITY(U,$J,358.3,47265,1,4,0)
 ;;=4^C81.21
 ;;^UTILITY(U,$J,358.3,47265,2)
 ;;=^5001412
 ;;^UTILITY(U,$J,358.3,47266,0)
 ;;=C81.22^^209^2346^333
 ;;^UTILITY(U,$J,358.3,47266,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47266,1,3,0)
 ;;=3^Mixed Cellularity Classical Hodgkin Lymphoma,Intrathoracic Nodes
 ;;^UTILITY(U,$J,358.3,47266,1,4,0)
 ;;=4^C81.22
 ;;^UTILITY(U,$J,358.3,47266,2)
 ;;=^5001413
 ;;^UTILITY(U,$J,358.3,47267,0)
 ;;=C81.23^^209^2346^334
 ;;^UTILITY(U,$J,358.3,47267,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47267,1,3,0)
 ;;=3^Mixed Cellularity Classical Hodgkin Lymphoma,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,47267,1,4,0)
 ;;=4^C81.23
 ;;^UTILITY(U,$J,358.3,47267,2)
 ;;=^5001414
 ;;^UTILITY(U,$J,358.3,47268,0)
 ;;=C81.24^^209^2346^335
 ;;^UTILITY(U,$J,358.3,47268,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47268,1,3,0)
 ;;=3^Mixed Cellularity Classical Hodgkin Lymphoma,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,47268,1,4,0)
 ;;=4^C81.24
 ;;^UTILITY(U,$J,358.3,47268,2)
 ;;=^5001415
 ;;^UTILITY(U,$J,358.3,47269,0)
 ;;=C81.25^^209^2346^336
